Novo Nordisk’s monlunabant showed signs of neuropsychiatric side effects in a mid-stage diabetic kidney disease study, despite a drug design intended to favor hitting its target receptor in peripheral tissues rather than the brain. Neuro effects were also reported last year in a Phase 2 test of this pill in obesity.
A study assessed the kidney benefits of metabolic surgery compared to glucagon-like peptide-1 receptor agonist treatment in patients with obesity and chronic kidney disease (CKD).
Nature Medicine – Improved muscle function, strength and fatigue measures were observed after electrical spinal cord stimulation in individuals with spinal muscular atrophy.
TBD on whether the game ends up sounding more immersive.
The USDA said four Nevada dairy herds were infected with an H5N1 bird flu strain which has circulated in wild birds, making prospects for containment…
The document charred by the eruption of Mount Vesuvius is being ‘unwrapped’ using X-ray scans and AI.
Dismantling of USAID could disrupt many clinical trials and wipe away U.S. “soft power” in developing countries, scientists warn
The employee sent the “Resign” email but has heard nothing back. “I feel like they ghosted me. Can I get an emoji at least?”
The suite of agentic Gemini 2.0 models includes 2.0 Flash, 2.0 Pro Experimental and 2.0 Flash-Lite.
Adelaide Hebert, MD, discusses the impact of the recent approval for tapinarof cream in the management of atopic dermatitis.
The biggest pharmacy benefit managers have made efforts to improve relationships with pharmacies, health insurers, employers and patients.
